Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Rivastigmine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,351Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis' Prometax (rivastigmine) Receives Approval in Europe
    Novartis' Prometax (rivastigmine) Receives Approval in Europe

    08 Jun 2023

    // EMA

    https://www.ema.europa.eu/en/medicines/human/EPAR/prometax#overview-section

    EMA
    08 Jun 2023
    Share Share
    Luye Pharma's Rivastigmine Transdermal Patch Receives Market Approval in China
    Luye Pharma's Rivastigmine Transdermal Patch Receives Market Approval in China

    08 Jun 2020

    // PRESS RELEASE

    https://www.luye.cn/lvye_en/view.php?id=1837

    PRESS RELEASE
    08 Jun 2020
    Share Share
    People often skip neurological meds when out-of-pocket costs rise
    People often skip neurological meds when out-of-pocket costs rise

    20 Feb 2020

    // Linda Carroll REUTERS

    https://www.reuters.com/article/us-health-neurology-drug-costs/people-often-skip-neurological-meds-when-out-of-pocket-costs-rise-idUSKBN20D2QG?feedType=RSS&feedName=healthNews

    Linda Carroll REUTERS
    20 Feb 2020
    Share Share
    Zydus Noveltech's Generic Rivastigmine Receives Approval in US
    Zydus Noveltech's Generic Rivastigmine Receives Approval in US

    06 Mar 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206318

    FDA
    06 Mar 2019
    Share Share
    Luye Pharma receives China approval for CNS drug
    Luye Pharma receives China approval for CNS drug

    23 Jul 2018

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/48/11343/luye-pharma-receives-china-approval-for-cns-drug.html

    BIOSPECTRUM
    23 Jul 2018
    Share Share
    Mylan launches generic drug-delivery patch for dementia patients
    Mylan launches generic drug-delivery patch for dementia patients

    09 Jul 2018

    // Sarah Faulkner DRUG DEL BUSINESS

    https://www.drugdeliverybusiness.com/mylan-launches-generic-drug-delivery-patch-for-dementia-patients/

    Sarah Faulkner DRUG DEL BUSINESS
    09 Jul 2018
    Share Share